v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   599,197      
Beginning balance at Dec. 31, 2020 $ 2,901,783 $ 60 $ 8,904,791 $ 2,639 $ (6,005,707)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,172,211)       (1,172,211)
Other comprehensive loss (4,839)     (4,839)  
Exercise of common stock options (in shares)   5,289      
Exercise of common stock options 47,793 $ 1 47,792    
Issuance of common stock upon settlement of RSUs, net of shares withheld (in shares)   3,571      
Issuance of common stock upon settlement of RSUs, net of shares withheld (15,054)   (15,054)    
Reclassification of derivative warrant liability to equity 1,277,168   1,277,168    
Purchase of capped calls (100,200)   (100,200)    
Stock-based compensation 224,983   224,983    
Ending balance (in shares) at Mar. 31, 2021   608,057      
Ending balance at Mar. 31, 2021 3,159,423 $ 61 10,339,480 (2,200) (7,177,918)
Beginning balance (in shares) at Dec. 31, 2021   633,524      
Beginning balance at Dec. 31, 2021 4,775,713 $ 63 11,140,284 (6,893) (6,357,741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (18,792)       (18,792)
Other comprehensive loss $ (5,522)     (5,522)  
Exercise of common stock options (in shares) 784 784      
Exercise of common stock options $ 11,652   11,652    
Issuance of common stock upon settlement of RSUs, net of shares withheld (in shares)   2,114      
Issuance of common stock upon settlement of RSUs, net of shares withheld (224,358) $ 1 (224,359)    
Stock-based compensation 198,723   198,723    
Ending balance (in shares) at Mar. 31, 2022   636,422      
Ending balance at Mar. 31, 2022 $ 4,737,416 $ 64 $ 11,126,300 $ (12,415) $ (6,376,533)